About 12.1M results
Open links in new tab
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Novartis Kisqali® shows deepening benefit in new analysis, …
News - Novartis
Novartis unveils new focused strategy, underpinned by eight …
New Novartis data in relapsing MS reinforce benefits of …
Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins …
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two ... - BioSpace
Novartis announces new organizational structure to
Novartis AG: Hold Rating Justified Amid Kisqali’s Market Potential …